3.91 0.105 (2.76%) | 02-14 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 4.76 ![]() |
1-year : | 5.56 ![]() |
Resists | First : | 4.07 ![]() |
Second : | 4.76 ![]() |
Pivot price | 3.56 ![]() |
|||
Supports | First : | 3.47 ![]() |
Second : | 3.09 |
MAs | MA(5) : | 3.79 ![]() |
MA(20) : | 3.52 ![]() |
MA(100) : | 3.51 ![]() |
MA(250) : | 5.63 ![]() |
|
MACD | MACD : | 0 ![]() |
Signal : | 0 ![]() |
%K %D | K(14,3) : | 81.6 ![]() |
D(3) : | 79.6 ![]() |
RSI | RSI(14): 62.3 ![]() |
|||
52-week | High : | 18.5 | Low : | 2.35 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ HSCS ] has closed below upper band by 16.2%. Bollinger Bands are 22.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 4.09 - 4.11 | 4.11 - 4.13 |
Low: | 3.73 - 3.76 | 3.76 - 3.79 |
Close: | 3.87 - 3.91 | 3.91 - 3.95 |
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Mon, 16 Dec 2024
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results - GlobeNewswire
Wed, 13 Nov 2024
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - GlobeNewswire
Tue, 24 Sep 2024
Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket - Benzinga
Tue, 24 Sep 2024
"Nasdaq Stocks Set for Explosive Growth: BNZI, SEEL, PRSO, MSS, HSCS Revamp for Big Potential" - openPR
Tue, 24 Sep 2024
“Nasdaq Stocks Set for Explosive Growth: BNZI, SEEL, PRSO, MSS, HSCS Revamp for Big Potential” - Barchart
Thu, 12 Sep 2024
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - GlobeNewswire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 0 (M) |
Shares Float | 1 (M) |
Held by Insiders | 826300 (%) |
Held by Institutions | 10.6 (%) |
Shares Short | 23 (K) |
Shares Short P.Month | 0 (K) |
EPS | -7.02e+006 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | -37 % |
Return on Assets (ttm) | 907.4 % |
Return on Equity (ttm) | -81.7 % |
Qtrly Rev. Growth | 18600 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | -81.86 |
EBITDA (p.s.) | 3805.47 |
Qtrly Earnings Growth | 5.3 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | -7 (M) |
PE Ratio | -0.01 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | -0.05 |
Price to Cash Flow | 1.18 |
Dividend | 0 |
Forward Dividend | 54950 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |